MicroRNAs in pemphigus and pemphigoid diseases

Area of Science:

• Dermatology
• Molecular Biology
• Immunology

Background:

• Autoimmune blistering diseases, including pemphigus and pemphigoid diseases (PPDs), are characterized by autoantibodies targeting skin adhesion proteins.
• Current diagnostic methods involve clinical evaluation, histopathology, immunofluorescence, and autoantibody detection, but pathogenesis and cures remain elusive.
• MicroRNAs (miRNAs), small non-coding RNAs regulating gene expression, are increasingly recognized for their role in various diseases.

Purpose of the Study:

• To review the current understanding of microRNAs (miRNAs) in the pathogenesis of pemphigus and pemphigoid diseases (PPDs).
• To explore the potential of miRNAs as biomarkers, predictive factors, and therapeutic targets in PPDs.
• To highlight the emerging role of miRNA research in advancing PPD diagnosis and treatment.

Main Methods:

• Literature review of studies investigating microRNAs in autoimmune blistering diseases.
• Analysis of existing data on miRNA expression and function in pemphigus and pemphigoid disease models and patients.
• Synthesis of information regarding the diagnostic and therapeutic potential of miRNAs in PPDs.

Main Results:

• Dysfunctional miRNAs are implicated in the pathogenesis of various diseases, with emerging evidence suggesting their role in PPDs.
• miRNA research in PPDs is still in its early stages but shows promise for uncovering new pathogenic mechanisms.
• miRNAs may serve as valuable biomarkers for diagnosis and prognosis, and as targets for future therapeutic interventions.

Conclusions:

• MicroRNAs represent a promising area of research for understanding the complex pathogenesis of PPDs.
• Further investigation into miRNAs could lead to improved diagnostic tools and novel therapeutic strategies for autoimmune blistering diseases.
• Targeting miRNAs may offer a new avenue for treating pemphigus and pemphigoid diseases.